8-K/A

FORM 8-K/A

Company: Eloxx Pharmaceuticals, Inc.
Filed: March 13, 2020
Period of Report: February 24, 2020
Accession Number: 0001104659-20-033093

View Document ↗ View on SEC.gov ↗